Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Royce & Associates reports amended beneficial ownership of Apyx Medical Corporation common stock. The firm beneficially owns 3,274,064 shares, representing 7.81% of the class as of June 30, 2026. It has sole power to vote and dispose of all reported shares and no shared voting or dispositive power.
The shares are held in investment management accounts of clients of Royce & Associates, LP, an indirect majority-owned subsidiary of Franklin Resources, Inc. Royce & Associates states the holdings are maintained in the ordinary course of business, disclaims pecuniary interest and beneficial ownership beyond Rule 13d-3, and indicates the position is not held to change or influence control of Apyx Medical Corporation.
Key Figures
Shares beneficially owned:3,274,064 sharesPercent of class:7.81%Sole voting power:3,274,064 shares+4 more
7 metrics
Shares beneficially owned3,274,064 sharesBeneficial ownership of Apyx Medical Corporation common stock reported by Royce & Associates
Percent of class7.81%Portion of Apyx Medical Corporation common stock class beneficially owned
Sole voting power3,274,064 sharesShares over which Royce & Associates has sole power to vote or direct the vote
Sole dispositive power3,274,064 sharesShares over which Royce & Associates has sole power to dispose or direct the disposition
CUSIP03837C106CUSIP number for Apyx Medical Corporation common stock
As-of date06/30/2026Date as of which the beneficial ownership information is stated
Signature date07/21/2026Date the certification was signed by the vice president
Key Terms
beneficial owner, sole voting power, sole dispositive power, pecuniary interest, +1 more
5 terms
beneficial ownerregulatory
"As a result, for purposes of Rule 13d 3 under the Act, RALP may be deemed to be the beneficial owner"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
sole voting powerfinancial
"Sole Voting Power 3,274,064.00 6 | Shared Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive powerfinancial
"Sole Dispositive Power 3,274,064.00 8 | Shared Dispositive Power 0.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
pecuniary interestregulatory
"RALP disclaims any pecuniary interest in any of the securities reported"
Schedule 13Gregulatory
"Beneficial ownership by investment management subsidiaries and other affiliates of FRI is being reported in conformity with the guidelines"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of Apyx Medical Corporation (APYX) stock does Royce & Associates report owning?
Royce & Associates reports beneficial ownership of 3,274,064 shares of Apyx Medical Corporation common stock, representing 7.81% of the outstanding class as of June 30, 2026, with sole voting and dispositive power over all reported shares.
Does Royce & Associates share voting or dispositive power over APYX shares with any other party?
No. Royce & Associates reports sole voting power over 3,274,064 shares and sole dispositive power over 3,274,064 shares, with 0 shared voting power and 0 shared dispositive power over Apyx Medical Corporation common stock.
Is Royce & Associates’ 7.81% APYX stake intended to influence control of the company?
Royce & Associates certifies the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing the control of Apyx Medical Corporation.
On whose behalf does Royce & Associates hold its Apyx Medical (APYX) position?
The APYX securities are beneficially owned by registered investment companies and other managed accounts that are investment management clients of Royce & Associates, LP, which exercises investment discretion and voting authority under applicable management agreements.
How is Royce & Associates related to Franklin Resources, Inc. in this APYX filing?
Royce & Associates, LP is described as an indirect majority owned subsidiary of Franklin Resources, Inc. The filing notes voting and investment powers are exercised independently from Franklin Resources and its other investment management subsidiaries.
Does Royce & Associates claim pecuniary interest in its APYX holdings?
No. Royce & Associates disclaims any pecuniary interest in the Apyx Medical Corporation securities and states that the filing should not be construed as an admission of beneficial ownership under Rule 13d-3.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)
Apyx Medical Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
03837C106
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
03837C106
1
Names of Reporting Persons
ROYCE & ASSOCIATES LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NEW YORK
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
3,274,064.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,274,064.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,274,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.81 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Apyx Medical Corporation
(b)
Address of issuer's principal executive offices:
Office of the President Buttonwood Advisory Group, Inc., Huntersville, NC, 28078
Item 2.
(a)
Name of person filing:
ROYCE & ASSOCIATES LP
(b)
Address or principal business office or, if none, residence:
One Madison Avenue, New York, NY 10010
(c)
Citizenship:
New York Corporation
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
03837C106
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
3274064.00
(b)
Percent of class:
7.81 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
3274064.00
(ii) Shared power to vote or to direct the vote:
0.00
(iii) Sole power to dispose or to direct the disposition of:
3274064.00
(iv) Shared power to dispose or to direct the disposition of:
0.00
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
ROYCE & ASSOCIATES LP
Signature:
Daniel A. O'Byrne
Name/Title:
Vice President
Date:
07/21/2026
Exhibit Information
The securities reported herein are beneficially owned by one or more registered investment companies or other managed accounts that are investment management clients of Royce & Associates, LP ("RALP"), an indirect majority owned subsidiary of Franklin Resources, Inc.("FRI"). When an investment management contract (including a sub advisory agreement) delegates to RALP investment discretion or voting power over the securities held in the investment advisory accounts that are subject to that agreement, FRI treats RALP as having sole investment discretion or voting authority, as the case may be, unless the agreement specifies otherwise. Accordingly, RALP reports on Schedule 13G that it has sole investment discretion and voting authority over the securities covered by any such investment managementagreement, unless otherwise noted in this Item 4. As a result, for purposes of Rule 13d 3 under the Act, RALP may be deemed to be the beneficial owner of the securities reported in this Schedule 13G. Beneficial ownership by investment management subsidiaries and other affiliates of FRI is being reported in conformity with the guidelines articulated by the SEC staff in Release No. 3439538 (January 12, 1998) relating to organizations, such as FRI, where related entities exercise voting and investment powers over the securities being reported independently from eachother. The voting and investment powers held by RALP are exercised independently from FRI(RALP's parent holding company) and from all other investment management subsidiaries of FRI (FRI, its affiliates and investment management subsidiaries other than RALP are, collectively, "FRI affiliates"). Furthermore, internal policies and procedures of RALP and FRI affiliates establish informational barriers that prevent the flow between RALP and the FRI affiliates of information that relates to the voting and investment powers over the securities owned by their respective investment management clients. Consequently, RALP and the FRI affiliates report the securities over which they hold investment and voting power separately from each other for purposes of Section 13 of the Act. Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") may each own in excess of 10% of the outstanding common stock of FRI and are the principal stockholders of FRI (see FRI's Proxy Statement-Stock Ownership of Certain Beneficial Owners). However, because RALP exercises voting and investment powers on behalf of its investment management clients independently of FRI affiliates, beneficial ownership of the securities reported by RALP is not attributed to the Principal Shareholders. RALP disclaims any pecuniary interest in any of the securities reported in this Schedule 13G. In addition, the filing of this Schedule 13G on behalf of RALP should not be construed as an admission that it is, and it disclaims that it is, the beneficial owner, as defined in Rule 13d 3, of any of such securities. Furthermore, RALP believes that it is not a "group" with FRI affiliates, the Principal Shareholders, or their respective affiliates within the meaning of Rule 13d 5 under the Act and that none of them is otherwise required to attribute to any other the beneficial ownership of the securities held by such person or by any persons or entities for whom or for which RALP or the FRI affiliates provide investment management services.
